Sei Medical Public Co., Ltd. · SET:SEI
Sei Medical Public — H1 2025 Earnings Presentation
23 slides from Sei Medical Public's earnings presentation, Aug 19, 2025
Slide 1: Opportunity Day
SEI Medical Public Company Limited “SEI” Opportunity Day Tuesday, August 19, 2025, at 11:30 am.
Slide 2: Agenda
Agenda 1 Company and Business Overview 2 Q1-Q2/2025 Highlights 3 2025 Envision 4 Opportunities 5 6 Q&A
Slide 3: Company and Business Overview
SEI Medical Public Company Limited or “SEI” “Company and Business Overview”
Slide 4: Company and Business Overview
Company and Business Overview SEI Medical Public Company Limited ชื่อย่อหลักทรัพย์ Issuer Name SEI Medical Public Company Limited ลักษณะการดำเนินธุรกิจ Core Business A leading distributor and service provider of a wide range of medical devices, disposable medical กลุ่มอุตสาหกรรม (Sector) supplies, a
Slide 5: Since Your Day One
Company and Business Overview Business Units 22 Brands “SINCE YOUR DAY ONE” 6 Product Groups Covering all Stages of Life Neonatal Care 1,000+ Endoscope Products Surgery Laboratory Aesthetic Intensive Care Unit (ICU)
Slide 6: Business Units - Products
Company and Business Overview Business Units - Products Neonatal Care Endoscope Surgery Laboratory Aesthetic Intensive Care Unit These are medical These are medical These are medical products These are scientific These are products for These are comprehensive instruments used for the instruments use
Slide 7: Trusted Partners
Company Overview Trusted Partners Manufacturers 22 Brands/Partners (+2 from Q2/2025) 1,000+ Products
Slide 8: Q1-Q2/2025 Highlights
SEI Medical Public Company Limited or “SEI” “Q1-Q2/2025 Highlights”
Slide 9: Financial Performance: Total Revenue
Q1-Q2/2025 Highlights Financial Performance Total Revenue (THB million) 250 “SEI Medical achieved robust revenue growth in the first half of 2025, 200 with total revenue surging 25.35% to THB 249.39 million. Y 249.39 Yo This growth was fueled by strong performance 5% .3 25 150 across all core operat
Slide 10: Financial Performance: Gross Profit and GPM
Q1-Q2/2025 Highlights Financial Performance Gross Profit and GPM (THB million) 100 “SEI Medical proved its profitability is 80 both scalable and resilient. The company boosted gross 81.17 profit by substantial 23.70% to THB 81.17 million, while y Yo 0% 60 .7 simultaneously defending its high gross m
Slide 11: Financial Performance: Net Profit and NPM
Q1-Q2/2025 Highlights Financial Performance Net Profit and NPM (THB million) “The 50.75% surge in net profit to THB 30.09 million was 35 magnified by an expanding net profit margin, 30 which increased to 11.95%. Y 30.09 25 Yo % NPM = 11.95% . 75 50 20 The margin improvement proves that 19.96 SEI Med
Slide 12: Strong Financial Position
Q1-Q2/2025 Highlights Financial Performance Strong Financial Position Asset Liabilities and Equity Liabilities (THB million) (THB million) Equity 500 500 400 400 487.68 291.39 461.10 281.70 300 300 200 200 196.29 100 100 179.40 0 0 Y/E 2024 6M/2025 Y/E 2024 6M/2025
Slide 13: Key Financial Takeaways
Q1-Q2/2025 Highlights Key Financial Takeaways The growth was attributed to an expanded customer base Sales and Service Revenue Growth and increased sales from new product lines. (45.36% on service and 23.45% on sales) Similarly, service revenue driven by a higher volume of completed work under maint
Slide 14: Q1-Q2 of 2025 Highlights
Q1-Q2 of 2025 Highlights Q1-Q2/2025 HIGHLIGHTS 249.39 MB 50.75% 45.36% New Milestone in Total Revenue Surge in Net Profit Skyrocketing Growth in Service Grew by 25.35% from 198.94 MB Rising to 30.09 MB from 19.96 MB Revenue to 25.06 MB
Slide 15: Q3-4/2025 Envision
SEI Medical Public Company Limited or “SEI” “Q3-4/2025 Envision”
Slide 16: Business Expansions
Q3-Q4 of 2025 Envision Business Expansions Our strategic direction includes the expansion of business units and the development of product lines. “In 2025, the company's Product strategic emphasis Hardwares on hardware sales, coupled with an expansion of service offerings and a focused approach Serv
Slide 17: External Factors
Q3-Q4 of 2025 Envision External Factors Growing Healthcare Demand: Driven by an aging population, rising health consciousness, and increase in Chronic Diseases. “The internal strategy Growing is further bolstered by Demand “external factors”, including growing healthcare demand, Government’s governm
Slide 18: Short-Term Factors
Q3-Q4 of 2025 Envision Short-Term Factors Product Hardwares Q4: Peak Procurement Season Q4 represents the peak season of the company, aligning with the government’s budget cycle for procurement Create critical opportunities to medical sector Service Consumable Products
Slide 19: JUMP+ Program
Q3-Q4 of 2025 Envision External Factors JUMP+ PROGRAM 1 Access to Advisory Service and Substantial Grants 2 Enhanced Corporate and Investor Visibility Access to an Advisory Pool for 3 Strategic Innovation Exploration of New Opportunities with 2 Greater Speed and Efficiency 3 Trend Identification and
Slide 20: 2025 Envision Summary
2025 Envision Summary 2025 ENVISION 20%+ 30%+ 25+ Targeting a 20% increase in Maintain high growth in service Expand more business units and total revenue in 2025 25+ partners/brands Currently: 25.35% Currently: 45.36% Currently: 22 Partners/Brands
Slide 21: Opportunities
SEI Medical Public Company Limited or “SEI” “Opportunities”
Slide 22: Opportunities
Opportunities Opportunities Positive Industry Outlook Clear Business Expansion Strategy Increase Market Presence Impressive Financial Performance Operational Efficiency
Slide 23: Since You Day One...
: >. 4" “SINCE YOU DAY O eS | ~Y a
SEI Medical Public Company — H1 2025 Earnings Presentation on 6ix